Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1328 | 2715 | 32.7 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
192 | 3 | GASTROESOPHAGEAL REFLUX DISEASE//GASTROESOPHAGEAL REFLUX//ESOPHAGEAL CANCER | 54156 |
1026 | 2 | GASTRIC CANCER//ADVANCED GASTRIC CANCER//GASTRECTOMY | 10242 |
1328 | 1 | ADVANCED GASTRIC CANCER//S 1//GASTRIC CANCER | 2715 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADVANCED GASTRIC CANCER | authKW | 1542268 | 9% | 55% | 249 |
2 | S 1 | authKW | 1174050 | 11% | 36% | 293 |
3 | GASTRIC CANCER | authKW | 1009501 | 41% | 8% | 1110 |
4 | METASTATIC GASTRIC CANCER | authKW | 286378 | 2% | 62% | 41 |
5 | LOCALLY ADVANCED GASTRIC CANCER | authKW | 169336 | 1% | 94% | 16 |
6 | DOCETAXEL | authKW | 123047 | 7% | 6% | 197 |
7 | CAPECITABINE | authKW | 111995 | 5% | 8% | 123 |
8 | SECOND LINE CHEMOTHERAPY | authKW | 111445 | 2% | 18% | 54 |
9 | OXALIPLATIN | authKW | 98840 | 5% | 6% | 140 |
10 | GASTROESOPHAGEAL CANCER | authKW | 97555 | 1% | 32% | 27 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 64700 | 78% | 0% | 2126 |
2 | Gastroenterology & Hepatology | 3950 | 12% | 0% | 330 |
3 | Surgery | 888 | 12% | 0% | 318 |
4 | Pharmacology & Pharmacy | 844 | 13% | 0% | 344 |
5 | Radiology, Nuclear Medicine & Medical Imaging | 194 | 5% | 0% | 124 |
6 | Medicine, General & Internal | 45 | 4% | 0% | 101 |
7 | Medicine, Research & Experimental | 4 | 2% | 0% | 47 |
8 | Infectious Diseases | 1 | 1% | 0% | 27 |
9 | Integrative & Complementary Medicine | 0 | 0% | 0% | 4 |
10 | Hematology | -0 | 1% | 0% | 23 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PATHOGEN BIOCHEM MED | 90704 | 0% | 73% | 11 |
2 | GASTROINTESTINAL ONCOL | 87408 | 3% | 9% | 87 |
3 | EPIDEMIOL CLIN INFORMAT MANAGEMENT | 59703 | 1% | 30% | 18 |
4 | YOUNG LEADERS PROGRAM | 53962 | 0% | 40% | 12 |
5 | UCCL | 48880 | 0% | 43% | 10 |
6 | GI CLIN TRIALS UNIT | 44980 | 0% | 100% | 4 |
7 | GASTROINTESTINAL ONCOL DIGEST ENDOSCOPY | 44061 | 1% | 28% | 14 |
8 | GASTROINTESTINAL MED ONCOL | 37945 | 2% | 5% | 64 |
9 | MED ONCOL | 34136 | 14% | 1% | 377 |
10 | KLINIKUM GROSSHADERN RADIAT ONCOL | 33735 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GASTRIC CANCER | 199033 | 4% | 16% | 110 |
2 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 29058 | 5% | 2% | 138 |
3 | ANNALS OF ONCOLOGY | 21585 | 5% | 2% | 126 |
4 | JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 19206 | 3% | 2% | 80 |
5 | ONCOLOGY | 13923 | 3% | 2% | 70 |
6 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 9629 | 2% | 1% | 59 |
7 | ANTI-CANCER DRUGS | 9600 | 2% | 2% | 53 |
8 | ONKOLOGIE | 6540 | 1% | 2% | 39 |
9 | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 6201 | 1% | 2% | 26 |
10 | JOURNAL OF CLINICAL ONCOLOGY | 6006 | 3% | 1% | 94 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADVANCED GASTRIC CANCER | 1542268 | 9% | 55% | 249 | Search ADVANCED+GASTRIC+CANCER | Search ADVANCED+GASTRIC+CANCER |
2 | S 1 | 1174050 | 11% | 36% | 293 | Search S+1 | Search S+1 |
3 | GASTRIC CANCER | 1009501 | 41% | 8% | 1110 | Search GASTRIC+CANCER | Search GASTRIC+CANCER |
4 | METASTATIC GASTRIC CANCER | 286378 | 2% | 62% | 41 | Search METASTATIC+GASTRIC+CANCER | Search METASTATIC+GASTRIC+CANCER |
5 | LOCALLY ADVANCED GASTRIC CANCER | 169336 | 1% | 94% | 16 | Search LOCALLY+ADVANCED+GASTRIC+CANCER | Search LOCALLY+ADVANCED+GASTRIC+CANCER |
6 | DOCETAXEL | 123047 | 7% | 6% | 197 | Search DOCETAXEL | Search DOCETAXEL |
7 | CAPECITABINE | 111995 | 5% | 8% | 123 | Search CAPECITABINE | Search CAPECITABINE |
8 | SECOND LINE CHEMOTHERAPY | 111445 | 2% | 18% | 54 | Search SECOND+LINE+CHEMOTHERAPY | Search SECOND+LINE+CHEMOTHERAPY |
9 | OXALIPLATIN | 98840 | 5% | 6% | 140 | Search OXALIPLATIN | Search OXALIPLATIN |
10 | GASTROESOPHAGEAL CANCER | 97555 | 1% | 32% | 27 | Search GASTROESOPHAGEAL+CANCER | Search GASTROESOPHAGEAL+CANCER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PASINI, F , FRACCON, AP , DE MANZONI, G , (2011) THE ROLE OF CHEMOTHERAPY IN METASTATIC GASTRIC CANCER.ANTICANCER RESEARCH. VOL. 31. ISSUE 10. P. 3543-3554 | 75 | 97% | 33 |
2 | JANUNGER, KG , HAFSTROM, L , NYGREN, P , GLIMELIUS, B , (2001) A SYSTEMATIC OVERVIEW OF CHEMOTHERAPY EFFECTS IN GASTRIC CANCER.ACTA ONCOLOGICA. VOL. 40. ISSUE 2-3. P. 309 -326 | 106 | 83% | 87 |
3 | WAGNER, AD , UNVERZAGT, S , GROTHE, W , KLEBER, G , GROTHEY, A , HAERTING, J , FLEIG, WE , (2010) CHEMOTHERAPY FOR ADVANCED GASTRIC CANCER.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 80 | 70% | 120 |
4 | WOHRER, SS , RADERER, A , HEJNA, A , (2004) PALLIATIVE CHEMOTHERAPY FOR ADVANCED GASTRIC CANCER.ANNALS OF ONCOLOGY. VOL. 15. ISSUE 11. P. 1585-1595 | 82 | 88% | 108 |
5 | ORDITURA, M , GALIZIA, G , SFORZA, V , GAMBARDELLA, V , FABOZZI, A , LATERZA, MM , ANDREOZZI, F , VENTRIGLIA, J , SAVASTANO, B , MABILIA, A , ET AL (2014) TREATMENT OF GASTRIC CANCER.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 7. P. 1635 -1649 | 59 | 60% | 92 |
6 | KIM, TY , OH, DY , BANG, YJ , (2015) CAPECITABINE FOR THE TREATMENT OF GASTRIC CANCER.EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. VOL. 9. ISSUE 12. P. 1471 -1481 | 59 | 87% | 1 |
7 | TER VEER, E , MOHAMMAD, NH , VAN VALKENHOEF, G , NGAI, LL , MALI, RMA , ANDEREGG, MC , VAN OIJEN, MGH , VAN LAARHOVEN, HWM , (2016) THE EFFICACY AND SAFETY OF FIRST-LINE CHEMOTHERAPY IN ADVANCED ESOPHAGOGASTRIC CANCER: A NETWORK META-ANALYSIS.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 108. ISSUE 10. P. - | 61 | 84% | 0 |
8 | JANUNGER, KG , HAFSTROM, L , GLIMELIUS, B , (2002) CHEMOTHERAPY IN GASTRIC CANCER: A REVIEW AND UPDATED META-ANALYSIS.EUROPEAN JOURNAL OF SURGERY. VOL. 168. ISSUE 11. P. 597-608 | 80 | 71% | 144 |
9 | KHAMLY, K , JEFFORD, M , MICHAEL, M , ZALCBERG, J , (2006) RECENT DEVELOPMENTS IN THE SYSTEMIC THERAPY OF ADVANCED GASTROESOPHAGEAL MALIGNANCIES.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 15. ISSUE 2. P. 131-153 | 93 | 65% | 5 |
10 | KANG, BW , KIM, JG , KWON, OK , CHUNG, HY , YU, W , (2014) NON-PLATINUM-BASED CHEMOTHERAPY FOR TREATMENT OF ADVANCED GASTRIC CANCER: 5-FLUOROURACIL, TAXANES, AND IRINOTECAN.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 18. P. 5396 -5402 | 53 | 91% | 4 |
Classes with closest relation at Level 1 |